BG51159A3 - Process for the preparation of 1h, 3h-pyrrhol(1,2-c)thiazole-7-carboxamide derivatives - Google Patents

Process for the preparation of 1h, 3h-pyrrhol(1,2-c)thiazole-7-carboxamide derivatives Download PDF

Info

Publication number
BG51159A3
BG51159A3 BG091500A BG9150090A BG51159A3 BG 51159 A3 BG51159 A3 BG 51159A3 BG 091500 A BG091500 A BG 091500A BG 9150090 A BG9150090 A BG 9150090A BG 51159 A3 BG51159 A3 BG 51159A3
Authority
BG
Bulgaria
Prior art keywords
radical
alkyl
phenyl
pyridyl
optionally substituted
Prior art date
Application number
BG091500A
Other languages
Bulgarian (bg)
English (en)
Inventor
Claude James
Daniel Lave
Francoise Soler
Original Assignee
Rhone-Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BG9284390A priority Critical patent/BG51455A3/xx
Application filed by Rhone-Poulenc Sante filed Critical Rhone-Poulenc Sante
Priority to BG092844A priority patent/BG50610A3/xx
Publication of BG51159A3 publication Critical patent/BG51159A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG091500A 1989-03-17 1990-03-16 Process for the preparation of 1h, 3h-pyrrhol(1,2-c)thiazole-7-carboxamide derivatives BG51159A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BG9284390A BG51455A3 (en) 1989-03-17 1990-03-06 Process for the preparation derivatives of 1h-3h-pyrol/1,2-c/thiazole-7-carboxamide
BG092844A BG50610A3 (en) 1989-03-17 1990-03-16 Method for the preparation of derivatives of 1h, 3h- pyrol (1, 2- c) thiazole- 7- carboxamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8903510A FR2644456B1 (fr) 1989-03-17 1989-03-17 Nouveaux derives du 1h, 3h-pyrrolo(1,2-c)thiazolecarboxamide-7, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
BG51159A3 true BG51159A3 (en) 1993-02-15

Family

ID=9379793

Family Applications (1)

Application Number Title Priority Date Filing Date
BG091500A BG51159A3 (en) 1989-03-17 1990-03-16 Process for the preparation of 1h, 3h-pyrrhol(1,2-c)thiazole-7-carboxamide derivatives

Country Status (24)

Country Link
US (1) US5086051A (es)
EP (1) EP0388309B1 (es)
JP (1) JPH02289586A (es)
KR (1) KR900014408A (es)
AT (1) ATE102210T1 (es)
BG (1) BG51159A3 (es)
CA (1) CA2012343A1 (es)
CS (2) CS438990A3 (es)
DD (1) DD297822A5 (es)
DE (1) DE69006872T2 (es)
DK (1) DK0388309T3 (es)
ES (1) ES2062432T3 (es)
FI (1) FI92069C (es)
FR (1) FR2644456B1 (es)
IE (1) IE63313B1 (es)
IL (1) IL93760A (es)
MA (1) MA21771A1 (es)
MX (1) MX26542A (es)
NO (1) NO172392C (es)
NZ (1) NZ232960A (es)
PL (1) PL284321A1 (es)
PT (1) PT93485B (es)
TN (1) TNSN90030A1 (es)
ZA (1) ZA902033B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW214545B (es) * 1992-02-17 1993-10-11 Ciba Geigy Ag
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
CA2140034A1 (en) 1992-07-13 1994-01-20 Xiong Cai 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
TW266206B (es) * 1993-04-28 1995-12-21 Takeda Pharm Industry Co Ltd
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) * 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5891895A (en) * 1996-04-15 1999-04-06 Takeda Chemical Industries, Ltd. Hydroxypyridine derivatives their production and use
JP5169216B2 (ja) * 2005-08-19 2013-03-27 独立行政法人産業技術総合研究所 色可逆変化表示装置用電極体及びその製造方法、並びに色可逆変化表示装置及び色可逆変化調光装置
WO2009125434A2 (en) * 2008-04-07 2009-10-15 Cadila Healthcare Limited Oxime derivatives
WO2014192023A1 (en) * 2013-05-22 2014-12-04 Cadila Healthcare Limited Novel compounds suitable for the treatment of dyslipidemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2541280B1 (fr) * 1983-01-13 1985-06-21 Rhone Poulenc Sante Nouveaux derives du 1h, 3h-pyrrolo (1,2c) thiazolecarboxamide-7, leur preparation et les medicaments qui les contiennent
FR2601016B1 (fr) * 1986-07-04 1988-10-07 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2601015B1 (fr) * 1986-07-04 1988-08-05 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
PT93485B (pt) 1996-02-29
FI92069B (fi) 1994-06-15
IE900984L (en) 1990-09-17
FR2644456B1 (fr) 1991-07-05
CS125290A3 (en) 1992-03-18
NO172392C (no) 1993-07-14
ES2062432T3 (es) 1994-12-16
PT93485A (pt) 1990-11-07
FR2644456A1 (fr) 1990-09-21
CS438990A3 (en) 1992-03-18
MA21771A1 (fr) 1990-10-01
DE69006872T2 (de) 1994-06-30
FI92069C (fi) 1994-09-26
PL284321A1 (en) 1991-07-29
DK0388309T3 (da) 1994-04-11
ATE102210T1 (de) 1994-03-15
CS276785B6 (en) 1992-08-12
JPH02289586A (ja) 1990-11-29
IL93760A (en) 1994-08-26
IE63313B1 (en) 1995-04-05
DE69006872D1 (de) 1994-04-07
US5086051A (en) 1992-02-04
KR900014408A (ko) 1990-10-23
CA2012343A1 (fr) 1990-09-17
DD297822A5 (de) 1992-01-23
TNSN90030A1 (fr) 1991-03-05
EP0388309A2 (fr) 1990-09-19
FI901325A0 (fi) 1990-03-16
ZA902033B (en) 1990-12-28
NO901237D0 (no) 1990-03-16
NZ232960A (en) 1991-02-26
MX26542A (es) 1993-09-01
NO172392B (no) 1993-04-05
EP0388309A3 (fr) 1991-07-24
IL93760A0 (en) 1990-12-23
NO901237L (no) 1990-09-18
EP0388309B1 (fr) 1994-03-02

Similar Documents

Publication Publication Date Title
BG51159A3 (en) Process for the preparation of 1h, 3h-pyrrhol(1,2-c)thiazole-7-carboxamide derivatives
DK575887D0 (da) Pyridinderivater med anti-ulcer aktivitet
HUP9802323A2 (hu) Pirimidinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyászati készítmények
BG60030B2 (bg) Метод за получаване на (d)-алфа-етил-2-оксо-1- пиролидинацетамид
FR2538388B1 (fr) Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments
ES479933A1 (es) Un procedimiento para la preparacion de derivados de amino- piridina.
DE68900717D1 (de) Chinolinonderivate, ihre herstellung und ihre verwendung als arzneimittel.
DK26289A (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
FR2659329B1 (fr) Nouveaux derives d'imidazo [1,2-c] quinazoline, leur procede de preparation et les compositions pharmaceutiques les renfermant.
NO913391L (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
ES8607953A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina
NO994764L (no) Nye pyridinderivater og farmasöytiske preparater inneholdende disse
DE59010865D1 (de) N-substituierte naphthalimide, ihre herstellung und verwendung
EP0169009A3 (en) Novel dihydropyridine derivatives and their production, formulation and use as pharmaceuticals
EP0325984A3 (en) 5-substituted 1-/4-(1-pyrrolidinyl)-2-butynyl/-2-pyrrolidones and related compounds, a process for their preparation and their use as medicaments
BG50610A3 (en) Method for the preparation of derivatives of 1h, 3h- pyrol (1, 2- c) thiazole- 7- carboxamide
FR2683221B1 (fr) Nouveaux derives de cinnolinones-4, leur preparation et leur application en therapeutique.
DK608586D0 (da) Polysubstituerede pyridin-1-oxider og fysiologisk aktive salte deraf, deres fremstilling og anvendelse som laegemidler
GR3026762T3 (en) Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same
ES8103747A1 (es) Procedimiento para la preparacion de 5,6,7,8-tetrahidropira-zolo (3,4-b)(1,5)diazepin-1h,4h-5,7-dionas
MY101878A (en) 1,3,4-thiadiazole